# Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab)

> **NCT01418430** · PHASE4 · COMPLETED · sponsor: **King's College Hospital NHS Trust**

## Conditions studied

- HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL)

## Interventions

- **DRUG:** CHOP-daclizumab

## Key facts

- **NCT ID:** NCT01418430
- **Lead sponsor:** King's College Hospital NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2011-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01418430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01418430, "Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01418430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*